SEC Form 4 · accession 0001209191-16-131361
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Burkhard Blank
Officer — Chief Medical Officer
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 8:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2016 | A | 40,000 | $0.00 | A | 40,000 | D | |
| Common StockF2 | Jul 1, 2016 | A | 10,000 | $0.00 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $25.99 | Jul 1, 2016 | A | 100,000 | A | — | Jul 1, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Restricted shares issued under the Company's 2015 Omnibus Incentive Compensation Plan. The shares will vest in four equal installments of 25% each with vest dates of December 1, 2016, December 1, 2017, December 1, 2018 and December 1, 2019.
- F2Restricted shares issued under the Company's 2015 Omnibus Incentive Compensation Plan. The shares will vest 50% on July 1, 2018 and 50% on July 1, 2019.
- F325% percent of the shares subject to this option vest on July 1, 2017. The balance of the shares subject to this option vest in equal quarterly installments over the three years thereafter.